PAPER Tian Y, Heinsinger N, Hu Y, Lim UM, Wang Y, Fernandis AZ, Parmentier-Batteur S, Klein B, Uslaner JM, Smith SM
SEARCH RESULTS
343741 RESULTS
PAPER Faller KM, Chaytow H, Gillingwater TH
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis.
Nat Rev Neurol. 2025 Jan 2; Epub 2025 Jan 2 PubMed.PAPER Li Z, Liu JP, Yao FH, Cao Y, Li SC, Liu YY, Wen SX, Liu YX, Liu AJ
Cold Inducible RNA-Binding Protein Promotes the Development of Alzheimer's Disease Partly by Inhibition of uPA in Astrocytes.
Degener Neurol Neuromuscul Dis. 2024;14:143-155. Epub 2024 Dec 27 PubMed.PAPER Inagaki Y, Kamikubo T, Kuriwaki I, Watanabe J, Yamaki S, Iida M, Tomita K, Kakefuda K, Kurokawa J, Kiso T, Saba K, Koike T
Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α-synucleinopathy.
Bioorg Med Chem. 2024 Dec 12;118:118042. Epub 2024 Dec 12 PubMed.PAPER Li R, Zhuang J
Diagnostic values of serum levels of α-synuclein, homocysteine and leucine-rich α2 glycoprotein for predicting cognitive impairment in Parkinson's disease.
Acta Neurol Belg. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER Yan M, Wu H, Wu T, Wang Y, Su C, Li D, Han X
Microcystin-LR Exposure Damages Neurons by Inducing α-Syn Aggregation via MAPK4/GATA2/SNCA and PP2A/GRKs Pathways.
Mol Neurobiol. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER Allegretti E, Mauti M, Coco MI
Visual short-term memory binding and attentional processes during object-scene integration are preserved in mild cognitive impairment.
Cortex. 2024 Dec 19; Epub 2024 Dec 19 PubMed.PAPER Ding X, Zuo Y, Liu Z, Sun Y, Wang L, Xie Y, Liu G, Liu C
Recombinant neurotrophin-3 with the ability to penetrate the blood-brain barrier: A new strategy against Alzheimer's disease.
Int J Biol Macromol. 2024 Dec 30;:139359. Epub 2024 Dec 30 PubMed.PAPER Zhou Y, Huang Z, Lin B, Ma M, Hao Y, Liu J, Xu W, Huang G, Mo W, Wang X, Jiang W, Zhou R
Demyelination-derived lysophosphatidylserine promotes microglial dysfunction and neuropathology in a mouse model of Alzheimer's disease.
Cell Mol Immunol. 2025 Jan 1; Epub 2025 Jan 1 PubMed.PAPER Zendehrouh E, Sendi MS, Abrol A, Batta I, Hassanzadeh R, Calhoun VD
Corrigendum to "A multimodal neuroimaging-based risk score for mild cognitive impairment" [NeuroImage: Clinical 45 (2025) 103719].
Neuroimage Clin. 2024 Dec 31;:103728. Epub 2024 Dec 31 PubMed. Corrected paper.PAPER O'Brien K, Largent EA, Karlawish J
Applying recommendations for diagnostic disclosure of mild cognitive impairment and dementia: Practical guidance for clinicians.
Alzheimers Dement. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER Yu ZY, Liu J, Liu ZH, Liu XY, Tuo JM, Li JH, Tu YF, Tan Q, Ma YY, Bai YD, Xin JY, Huang S, Zeng GH, Shi AY, Wang J, Liu YH, Bu XL, Ye LL, Wan Y, Liu TF, Chen XW, Qiu ZL, Gao CY, Wang YJ
Roles of blood monocytes carrying TREM2R47H mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice.
Alzheimers Dement. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER Erickson CM, Largent EA, O'Brien KS
Paving the way for Alzheimer's disease blood-based biomarkers in primary care.
Alzheimers Dement. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER Karneboge J, Haberstroh J, Geschke K, Perry J, Radenbach K, Jessen F, Rostamzadeh A
Facing the new diagnostic and treatment options of Alzheimer's disease: The necessity of informed consent.
Alzheimers Dement. 2024 Dec 30; Epub 2024 Dec 30 PubMed.PAPER VandeVrede L, Schindler SE
Clinical use of biomarkers in the era of Alzheimer's disease treatments.
Alzheimers Dement. 2024 Dec 30; Epub 2024 Dec 30 PubMed.Current Filters
No filters selected